Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : AMLN (DIABETES DRUGS) -- Ignore unavailable to you. Want to Upgrade?

To: The Gambler who wrote (1099)	2/6/1998 1:29:00 AM
From: D.Right	Read Replies (1) \| Respond to of 2173

Dear Gambler: It is still a momentum thing (we just need a small spark to turn it around). As far as value is concerned, even with one year delay, it should have a market cap not to much different from its value at this time last year. But, if everything is logical, all the smart guys on Wall Street will lose their job because nobody will ever need their guide anymore. If you ask me, I believe the completion of trial enrollment will be the spark we need to get it rolling. D.Right

To: The Gambler who wrote (1099)	2/6/1998 5:57:00 PM
From: Harry Ehrlich	Read Replies (1) \| Respond to of 2173

Gambler, my feeling is that you are correct. I think that AMLN is a good investment. D Right mentioned in an earlier post that several test subjects were continuing with the product, even though the test was over. I suspect that they felt better and possibly enjoyed some weight loss. That post confirmed to me that this was a good speculative play. I also agree that there is not much downside. I am a position trader, holding stocks for several hours to several months. I bought in at 4 15/16 after that large reversal day. I tried to get in at 4 3/4 but was not fast enough that night. I got in the next morning at 4 15/16. But I bailed at 5 1/8, when I saw the price dropping the other day. Sometimes those reversal days have good follow through and sometimes they don't. I suspect the market wants to re-test that recent low. If that happens, I plan on jumping back in, as drops below 5 will present excellent buying opportunities. The other possibility is that J&J will buy Amylin. Good luck, Harry